PRESS: Celadon becomes first UK cannabis-based medicine group to win right to sell cannabis to the pharmaceutical industry in Britain
Exciting news! We are thrilled to announce that Celadon Pharmaceuticals has been featured in the Financial Times for becoming the first UK cannabis-based medicine group to win the right to sell cannabis to the pharmaceutical industry. We look forward to continuing to lead the way in this exciting and rapidly growing field.
Read More: https://www.ft.com/content/e0954eb4-af0a-45ed-8d43-267de7da7337
OTHER POSTS
-
PRESS: Britain could be getting high on the benefits of a full-scale medical cannabis industry
-
PRESS: British Pain Society features Celadon Pharmaceuticals Plc
-
PRESS: Celadon Pharmaceutical’s CEO Jim Short featured discussing new MHRA framework
-
PRESS: Inside huge top-secret legal cannabis facility hidden away in Birmingham that is the size of three football pitches